marsplanet

World citizen

[marsplanet @sunshine43223]

@TulsiGabbard Please try #leronlimab for your husband cancer treatment, potential results.

[marsplanet @sunshine43223]

@DNIGabbard #leronlimab is the cure for your Husband's cancer

[marsplanet @sunshine43223]

@TulsiGabbard Please try a miracle drug for any cancer # leronlimab

[marsplanet @sunshine43223]

@TulsiGabbard @ODNIgov Please try #leronlimab its a #ccr5 moa, may help on bone cancer

[marsplanet @sunshine43223]

@iam_RaviMohan The only solution to your problem is please Read this book. The secret Mind by Bonnie. Only Your mind knows all your problem and only can give the solution.

[Vignesh @vignesh_1718]

My humble request to @CMOTamilnadu

Savukku Shankar (@SavukkuOfficial) is an independent journalist who was framed and unlawfully jailed, he needs to be released or need a public statement on the proceedings of the case.

Many of us do have difference of opinion with Mr. Shankar but he was framed for no fault of his own just because he reported about the previous government.

In Tamil Nadu, there are journalists who have faced similar harassments from the previous government. They need to be free to report, criticise and educate the public.

Hopefully our government will do the needful.

CC - @tnpoliceoffl @TVKVijayHQ

[Everett, West Seattle @EverettRockford]

@WSJ https://t.co/Qn1P7b863k Fakenews WS Journal

[Science Translational Medicine @ScienceTM]

This week, researchers leverage adeno-associated vectors to deliver the CCR5-blocking HIV drug #leronlimab and show that a single dose elicits leronlimab expression and can partially suppress SHIV in infected macaques for as long as one year. @OHSUNews https://t.co/r4qdXXhCWE

[アヒシュ @Revenge_tower]

இந்த கஞ்சா ஆட்சியில் கஞ்சாவை டோர் டெலிவரி செய்த திருடர்கள் இளைஞர் களின் வாழ்க்கையை சீரழிக்கும் திமுக ஆட்சி இதற்கு தத்தி ஸ்டாலின் தான் பொறுப்பு

[Hari @hari_noty]

🚨 Say No To DMK 🚨

Remember this Photo ‼️

Before Voting to DMK 🙏🏻

[Julia Mitchell @UsNdHealth]

LOOK at these results! The enriched regimen shows real promise for MSS colorectal cancer. Fantastic work on the trial! 👏👏👏

[Pashtoon Kasi MD, MS @pashtoonkasi]

🆕🗞️Just out
🪺#NEST-1 trial results👇🏾

Are we on the verge of a new drug combo for colon or rectal cancer?

Substantial & brisk responses to just☝🏾dose of BOT🟢➕BAL🔹🔹 immunotherapy.🙌🏾

Pattern & kill is unprecedented🌊.

@ASCO #GI24 @OncoAlert
Abstract 117📍Poster Board H2

[Pashtoon Kasi MD, MS @pashtoonkasi]

#AACR26 Excited & honored to unveil initial results from the phase-2 CLOVER ☘️ trial.

CCR5-targeting
Leronlimab with
Oral chemotherapy &
VEGF-inhibitor
Enriched
Regimen

🏃‍♂️to our session
🔖 2-5PM
📍Section41🪧Poster14

👇🏽Promising #ctDNA💦📉
MSS #ColorectalCancer

@OncoA@OncoAlert

[kishore k swamy 🇮🇳 @sansbarrier]

நியாபகம் இருக்கா ? ஒரு வயதான பெண்ணை வீடு புகுந்து பீ அள்ளி ஊற்றி அவமானப்படுத்தி மிரட்டிய கும்பல் , அந்த பெண் சில நாட்களுக்கு முன் தனது மகனை பார்க்கவும் முடியாமல் மரணித்துப்போனார். இதைச்செய்தவர்களுக்கு சட்டம் எதுவும் செய்யாது. நீங்கள் செய்யலாம். மறக்காதீர்கள்.

[Ozmosi @OzmosiHealth]

$CYDY +nan% today

CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026

More Info: https://t.co/QjvyaGEVQy

[Rare Diseases @CheckOrphan]

CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 - For More Information Visit https://t.co/EKHwjrLiyD #CytoDyn #Breast_Cancer #Rare_Diseases #TNBC #Orphan_Drugs #Cancer_Research #Leronlimab

[Nieves Martinez Lago MD PhD @DraMartinezLago]

🧪 Leronlimab (anti-CCR5) FTP/TPI+BEV in rmCRC (#AACR2026, 6466)
📊 Phase II ongoing (n=10)
🔹 100% CCR5 expression
🔹 Early ↓CEA/CA19-9/ctDNA (4/4 pts in one site)
🔹 ↑PD-L1, ↓CTCs/CAMLs
🔹 Safety: no unexpected signals
💥 CCR5: emerging immunomodulatory target
🔗 https://t.co/MWwWN6RhE3
@AACR @GrupoTTD @myESMO

[Raffaele Di Giacomo, PhD @sciqst]

Interesting insights into the potential of Leronlimab as an anti-CCR5 agent in metastatic colorectal cancer (mCRC). The preliminary drop in biomarkers and alteration in immune markers like PD-L1 is intriguing. Could these changes indicate a longer-term clinical benefit? It will be interesting to see larger studies that validate these findings. For those curious about emerging treatments in oncology, platforms like Sci-Quest can deepen your understanding and generate comprehensive biomedical reviews. Check it out at: https://t.co/4Y9Imt92yh #Medicine #Oncology

[Journal of Experimental & Clinical Cancer Research @JournalofExper1]

New!

𝐓𝐡𝐞 𝐫𝐨𝐥𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐭𝐮𝐦𝐨𝐫 𝐦𝐢𝐜𝐫𝐨𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭 𝐢𝐧 #𝐝𝐫𝐮𝐠𝐫𝐞𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞 𝐚𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧 ��𝐧 𝐥𝐮𝐧𝐠 𝐬𝐪𝐮𝐚𝐦𝐨𝐮𝐬 𝐜𝐞𝐥𝐥 𝐜𝐚𝐫𝐜𝐢𝐧𝐨𝐦𝐚

👇
https://t.co/tC2bKAjp8R

#TumorMicroenvironment
#LungSquamousCellCarcinoma